Theravance Biopharma, Inc. develops and commercializes pharmaceutical products, including the FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of chronic obstructive pulmonary disease (COPD). The company serves patients and healthcare providers through its focus on respiratory therapies.
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.